Hematology

>

Latest News

AIMS65 Could Predict Treated Gastrointestinal Bleed Death, Rebleed Risks
AIMS65 Could Predict Treated Gastrointestinal Bleed Death, Rebleed Risks

October 27th 2024

New late-breaking ACG 2024 data supports AIMS65 as a risk factor tool for patients undergoing anticoagulant reversal.

AND017 Receives FDA Orphan Drug Designation for Sickle Cell Disease | Image Credit: US Food and Drug Administration
AND017 Receives FDA Orphan Drug Designation for Sickle Cell Disease

October 25th 2024

Anemia Notably Impacts Heart Failure Prognosis, Study Finds| Image Credit: Fotolia
Anemia Notably Impacts Heart Failure Prognosis, Study Finds

October 14th 2024

Cognitive Dysfunction Common in Patients with Sickle Cell Anemia | Image Credit: Jan Krivec/Unsplash
Cognitive Dysfunction Common in Patients with Sickle Cell Anemia

October 14th 2024

FDA logo
FDA Approves Marstacimab-hncq (Hympavzi) for Hemophilia A or B Without Inhibitors

October 11th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.